DifGen

Miramar, USA
DifGen is engaged in developing and manufacturing pharmaceutical solutions.
Request Access

About DifGen

DifGen is a company based in Miramar, USA. It operates as a Direct-to-Consumer (D2C), and B2B2C. DifGen has completed 2 acquisitions, including Aveva and KriGen Pharmaceuticals. DifGen offers products and services including Generic Pharmaceuticals, Branded Generics, and Transdermal Systems.

  • Headquarter Miramar, USA
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Aveva

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of DifGen

DifGen offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals, Branded Generics, and Transdermal Systems. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Generic drugs are produced for affordable healthcare solutions.

Branded generics are offered for accessible medical treatments.

Advanced transdermal patches are manufactured for drug delivery.

People of DifGen
Headcount 200-500
Employee Profiles 19
Employee Profiles
People
Rakesh Kumar Shekhar
Sr. Director, Engineering & Maintenance
People
Roland Lobo
Commissioning And Qualification Engineer
People
Santhanakrishnan Srinivasan
Founder & Co-CEO
People
Ramandeep Singh Jaj
Founder & Co-CEO

Unlock access to complete

Funding Insights of DifGen

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by DifGen

DifGen has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Aveva and KriGen Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Injectable pharmaceuticals are manufactured by KriGen Pharmaceuticals as a CDMO.
2018
Drugs for multiple therapeutic areas are manufactured by Aveva.
2003
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - DifGen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Difgen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DifGen

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Difgen

Frequently Asked Questions about DifGen

What does DifGen do?

DifGen Pharmaceuticals is involved in the development, manufacturing, and supply of high-quality generic and branded generic products. The company operates across various dosage forms, focusing on complex generics and advanced transdermal systems through its subsidiary, Aveva Drug Delivery Systems Inc. Expertise is maintained in research and development, regulatory compliance, and supply chain management to ensure access to essential medicines. Solutions are provided for healthcare sectors, emphasizing affordability and innovation to improve patient outcomes globally.

What products or services does DifGen offer?

DifGen offers Generic Pharmaceuticals, Branded Generics, and Transdermal Systems.

How many acquisitions has DifGen made?

DifGen has made 2 acquisitions, including Aveva, and KriGen Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available